Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 852181-03-4 | MDL No. : | MFCD11100079 |
Formula : | C5H5BrN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DYHJNZNZJCTGGW-UHFFFAOYSA-N |
M.W : | 205.01 | Pubchem ID : | 51063808 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 38.15 |
TPSA : | 55.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.91 cm/s |
Log Po/w (iLOGP) : | 1.06 |
Log Po/w (XLOGP3) : | 0.9 |
Log Po/w (WLOGP) : | 0.88 |
Log Po/w (MLOGP) : | 0.02 |
Log Po/w (SILICOS-IT) : | 0.45 |
Consensus Log Po/w : | 0.66 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.98 |
Solubility : | 2.14 mg/ml ; 0.0104 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.64 |
Solubility : | 4.67 mg/ml ; 0.0228 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.03 |
Solubility : | 19.2 mg/ml ; 0.0935 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With trifluoroacetic acid; In dichloromethane; at 20.0℃; for 12.0h; | At room temperature, 645 mg (2.47 mmol) oftert-butyl 2-bromo- 1-methyl-i H-imidazole-4-carboxylatewere stirred in a mixture of 1.7 g of trifluoroacetic acid andml of dichloromethane for 12 hours. The solvent wasremoved. The evaporation residue obtained consisted to95% of the target product 2-bromo-i -methyl-1H-imidazole4-carboxylic acid, which corresponds to a virtually quantitative yield.log P[a]: 0.0; 1H-NMR (CD3CN, 400 MHz); delta = 3.65 (s, 3H),7.78 (s, 1H) ppm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With oxalyl dichloride; N,N-dimethyl-formamide; In dichloromethane; toluene; for 4.0h; | 0.32 ml of oxalyl chloride (1.2 eq.) were added dropwise to a solution of 681 mg (3.32 mmol) of 2-bromo- i-methyl-1H-imidazole-4-carboxylic acid in 7 ml of dichloromethane and 3 drops of dimethylformamide. Afier 4 hours, the mixture was evaporated to dryness. 10 ml of dichloromethane, 359 mg (1 eq.) of N-methylpyridine-3- amine and 6 eq. of N,N-diisopropylethylamine were added to the residue and the mixture was then stirred for one hour. The mixture was then evaporated to dryness and the residue was chromatographed by MPLC on silica gel using the mobile phase ethyl acetate/methanol. Yield 411 mg (43% of theory). log P[n]: 0.76; 1H-NMR (CD3CN, 400 MHz); delta=3.41 (s, 3H);3.51 (s, 3H), 7.28-7.35 (m, 2H), 7.59-7.61 (m, 1H), 8.37-8.43 (m, 2H) ppm. |
[ 883876-21-9 ]
Methyl 2,5-dibromo-1H-imidazole-4-carboxylate
Similarity: 0.78
[ 120781-02-4 ]
Methyl 2-bromo-1-methyl-1H-imidazole-5-carboxylate
Similarity: 0.73
[ 95470-42-1 ]
Ethyl 2-bromo-4-methyl-1H-imidazole-5-carboxylate
Similarity: 0.72
[ 1093261-46-1 ]
Methyl 5-bromo-1H-imidazole-4-carboxylate
Similarity: 0.69
[ 74478-93-6 ]
Ethyl 2-bromo-1H-imidazole-5-carboxylate
Similarity: 0.68
[ 41716-18-1 ]
1-Methyl-1H-imidazole-4-carboxylic acid
Similarity: 0.84
[ 80304-42-3 ]
1,5-Dimethyl-1H-imidazole-4-carboxylic acid
Similarity: 0.74
[ 18075-64-4 ]
1-Phenyl-1H-imidazole-4-carboxylic acid
Similarity: 0.70
[ 1457-58-5 ]
2-Methyl-1H-imidazole-5-carboxylic acid
Similarity: 0.69
[ 138891-51-7 ]
Imidazo[1,5-a]pyridine-1-carboxylic acid
Similarity: 0.66
[ 41716-18-1 ]
1-Methyl-1H-imidazole-4-carboxylic acid
Similarity: 0.84
[ 883876-21-9 ]
Methyl 2,5-dibromo-1H-imidazole-4-carboxylate
Similarity: 0.78
[ 80304-42-3 ]
1,5-Dimethyl-1H-imidazole-4-carboxylic acid
Similarity: 0.74
[ 120781-02-4 ]
Methyl 2-bromo-1-methyl-1H-imidazole-5-carboxylate
Similarity: 0.73
[ 95470-42-1 ]
Ethyl 2-bromo-4-methyl-1H-imidazole-5-carboxylate
Similarity: 0.72